Back to the Media roomImmuPharma targets regulatory approval as follow-up study confirms “outstanding” safety profile of Lupuzor™ – Proactive Investors 12th August 2019To view commentary click here Share this article Share on Facebook Share on Twitter
ImmuPharma targets regulatory approval as follow-up study confirms “outstanding” safety profile of Lupuzor™ – Proactive Investors 12th August 2019To view commentary click here
